Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has issued several alerts and notices in mid-2026, including a recall of defective needles, a warning on counterfeit Pulmicort, and the blacklisting of Onifam Laboratories for regulatory violations. These actions underscore the agency's heightened vigilance on product quality and compliance, signaling to SMBs in the pharmaceutical and medical device sectors the critical need for robust quality assurance and regulatory adherence.
Pharmaceuticals
Medical Devices
Healthcare
Import/Export
Food and Beverage
Public Alert No. 042/2026- Alert on the Presence of Whitish Particulate Matter in Deleject Disposable Needles Batch No. 240605
NAFDAC
NAFDAC alerts the public to the presence of whitish particulate matter in Deleject Disposable Needles (Batch No. 240605), prompting a recall and investigation.
SMBs in the medical device supply chain must immediately quarantine affected batches, notify customers, and review their quality control processes to avoid distribution of defective products.
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC celebrates World Breastfeeding Week, emphasizing its commitment to promoting breastfeeding and regulating infant nutrition products.
SMBs in the baby food and nutrition sector should align with NAFDAC's promotional campaigns and ensure compliance with regulations on breast milk substitutes to avoid penalties.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC provides guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs, emphasizing their role in assessing complaints and product quality issues.
Medical device and IVD manufacturers and importers must establish robust procedures for creating, submitting, and responding to MIRs to ensure timely risk mitigation and regulatory compliance.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklists Onifam Laboratories Ltd and associated persons/entities from pharmaceutical business activities due to regulatory misrepresentation and improper use of approvals.
SMBs in the pharmaceutical sector must conduct thorough due diligence on business partners and ensure transparent regulatory practices to avoid association with blacklisted entities.
Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
NAFDAC
NAFDAC warns of suspected counterfeit Pulmicort (Budesonide) inhalation suspension in the market, infringing on AstraZeneca's marketing authorization.
Pharmacies and distributors must verify product authenticity through NAFDAC's verification systems and report any suspicious products to prevent distribution of counterfeit medicines.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON leverages an e-platform to facilitate international trade, streamlining processes for exporters and importers.
SMBs engaged in international trade should utilize SON's e-platform to expedite certification and compliance, reducing delays and costs.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC Nigeria for export purposes, highlighting the steps and benefits.
SMBs in aquaculture should follow NEPC registration guidelines to access export markets, ensuring compliance with export standards and boosting revenue.
Heightened enforcement by NAFDAC on product quality and regulatory compliance in pharmaceuticals and medical devices.
Increased scrutiny on counterfeit products, requiring robust anti-counterfeiting measures.
Opportunities for SMBs to leverage digital platforms for trade facilitation and export registration.
Need for enhanced due diligence when partnering with suppliers and distributors in the healthcare sector.
1
Review and strengthen quality assurance protocols for medical devices and pharmaceuticals.
2
Implement batch tracking and recall procedures to respond swiftly to product alerts.
3
Verify the authenticity of all pharmaceutical products before distribution.
4
Conduct due diligence on business partners to avoid associations with blacklisted entities.
5
Utilize SON's e-platform for trade certification and NEPC for export registration.
6
Stay updated with NAFDAC alerts and guidelines to ensure ongoing compliance.